Epigral aims for ₹5,000 crore revenue by FY31, says CMD
By United One News · AI-generated summary of 1 outlets' reporting
Published
AI-generated summary of the coverage listed below:
- Epigral plans capacity scale‑ups to reach ₹5,000 crore revenue by FY31.
- It expects ₹2,900 crore revenue this fiscal year, up from ₹2,500–2,530 crore in 2026.
Covered by 1 outlet across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
Capacity scale-ups to drive Epigral's ₹5,000 crore target by FY31: CMD Maulik Patel
Timeline
First reported by The Hindu BusinessLine on ; 1 article from 1 outlets so far.
Who is covering this story
- Center (1): The Hindu BusinessLine
Sources
- Capacity scale-ups to drive Epigral's ₹5,000 crore target by FY31: CMD Maulik Patel — The Hindu BusinessLine (center, AI-estimated) ·